Table 1.
OATP1B1 Inhibition (20μM); 20% Threshold had 77 ‘active’ and 399 ‘inactive’ compounds. Values represent 5-fold nested cross validation averages (*DL = 20% hold-out set). The rank normalized score is a normalized average of each of these metrics.
| Method Name |
AUC | F1- Score |
ACC | Recall | Specificity | Precision | Cohen's Kappa |
MCC | Rank Normalized Score |
|
|---|---|---|---|---|---|---|---|---|---|---|
| ada | 0.71 | 0.07 | 0.84 | 0.04 | 1.00 | 0.40 | 0.05 | 0.10 | 0.52 | |
| bnb | 0.81 | 0.34 | 0.85 | 0.26 | 0.97 | 0.67 | 0.28 | 0.33 | 0.65 | |
| DL* | 0.74 | 0.42 | 0.85 | 0.31 | 0.96 | 0.63 | 0.34 | 0.37 | 0.66 | |
| knn | 0.73 | 0.40 | 0.86 | 0.30 | 0.97 | 0.64 | 0.33 | 0.37 | 0.65 | |
| lreg | 0.77 | 0.36 | 0.85 | 0.27 | 0.96 | 0.65 | 0.29 | 0.34 | 0.65 | |
| rf | 0.79 | 0.41 | 0.86 | 0.30 | 0.97 | 0.69 | 0.34 | 0.38 | 0.67 | |
| svc | 0.80 | 0.41 | 0.63 | 0.81 | 0.59 | 0.28 | 0.23 | 0.30 | 0.60 | |
| xgb | 0.78 | 0.37 | 0.85 | 0.29 | 0.95 | 0.55 | 0.29 | 0.31 | 0.64 |